Øresund Pharma ApS: Financial statements 2021
CVR: 39492059
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Øresund Pharma ApS (CVR 39492059) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 7,275,387 and a net result of DKK 281,255 compared with DKK -86,083 the year before. That is an increase of 164.1% compared with the year before. Equity in the 2021 report amounted to DKK 3,390,044. The solvency ratio was 14.2%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 7,275,387
- Profit/Loss
- DKK 281,255
- Equity
- DKK 3,390,044
- Total Assets
- DKK 23,913,169
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 7.3 mio. | 281 t. | 3.4 mio. | 5 |
| 2020 | - | 2.8 mio. | -86 t. | 3.1 mio. | 4 |
| 2019 | - | 4.9 mio. | 2.6 mio. | 2.7 mio. | 3 |
Official annual report
Find more companies like Øresund Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 9, 2021, A/S PSE 17 NR. 1056 has been appointed auditor of Øresund Pharma ApS.
As of December 9, 2021, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of Øresund Pharma ApS.
Øresund Pharma ApS has published its annual report for 2020. Gross profit came to DKK 2,754,994, and the net result was DKK -86,083.
About Øresund Pharma ApS
Øresund Pharma ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Øresund Pharma IVS. The management consists of Patrick Halborg Cohn and Svend Aage Johansen. The company is owned by Machpali ApS and ESH Holding 2019 ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 39,702,011 and a net result of DKK 6,466,876 compared with DKK 13,707,320 the year before. Equity in the 2025 report amounted to DKK 44,617,595.